Johnson & Johnson forecasts as much as 6% sales growth in 2024
Johnson & Johnson on Tuesday forecast revenue growth of 5-6% for the next year, as it banks on strong demand…
18,290€
4,51%
Echtzeit-Aktienkurs JOHNSON MATT. LS 1,101698
Bid:
Ask:
Nachrichten zur JOHNSON MATT. LS 1,101698 Aktie
Johnson & Johnson forecasts as much as 6% sales growth in 2024
…
Johnson & Johnson forecasts as much as 6% sales growth in 2024 By Reuters
Johnson & Johnson forecasts as much as 6% sales growth in 2024…
Multiple Myeloma Market revenue to surpass USD 71 Billion by 2035, says Research Nester
Major multiple myeloma market players include Amgen Inc., Johnson & Johnson, Takeda Pharmaceuticals Company Limited, Novartis AG, Sanofi, Teva Pharmaceuticals…
Buffett Just Sold Dividend Kings Johnson & Johnson And Procter & Gamble - Buy This One Instead
…
Stocks To Watch: Big Week On Tap For McDonalds, Shopify, GameStop, And Johnson & Johnson
…
Johnson & Johnson transition underway, UBS assesses upcoming analyst day By Investing.com
Johnson & Johnson transition underway, UBS assesses upcoming analyst day…
Here are Fridays biggest analyst calls: Tesla, Boeing, Amazon, Delta, Spotify, Alibaba, Johnson & Johnson & more
Here are the biggest calls on Wall Street on Friday.…
Johnson & Johnson: Gewinnwarnung – deswegen steigt die Aktie
Gewinnwarnungen haben in den meisten Fällen keine guten Auswirkungen auf die Kursentwicklung einer Aktie. Das dies anders geht, beweist der…
Johnson & Johnson: Hochstufung im Vorfeld des Analystentags - Aktienanalyse
Zürich (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von der UBS:
Danielle Antalffy, Analystin der UBS, rät in einer aktuellen Aktienanalyse zum Kauf…
Johnson & Johnson: Die Börse bewertet die Übernahme von Laminar positiv - Aktienanalyse
Kulmbach (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von "Der Aktionär":
Jürgen Dreifürst vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Johnson &…
Märkte am Morgen: Siemens, Siemens Energy, Fresenius, Bechtle, Tesla, Johnson & Johnson, Elastic
Es läuft wieder rund am deutschen Aktienmarkt. Der November war für den DAX mit einem Plus von 9,5 Prozent der…
Johnson & Johnson: Sleep Well At Night With The Only AAA-Rated Dividend Aristocrat
…
NYSE-Titel J&J-Aktie dennoch fester: Johnson & Johnson veröffentlicht Gewinnwarnung infolge der Laminar-Übernahme
Für die Übernahme floss nach Konzernangaben vom Donnerstag eine Vorauszahlung von 400 Millionen US-Dollar. Dabei falle für den Zukauf ein…
Johnson & Johnson übernimmt Medizintechnikspezialist Laminar - Ziele angepasst
NEW BRUNSWICK (dpa-AFX) - Der Pharma- und Medizintechnikkonzern Johnson & Johnson übernimmt den bisher privat geführten Medizintechnikanbieter Laminar…
Johnson & Johnson übernimmt Medizintechnikspezialist Laminar
NEW BRUNSWICK (dpa-AFX) - Der Pharma- und Medizintechnikkonzern Johnson & Johnson übernimmt den bisher privat geführten Medizintechnikanbieter Laminar und passt…
: Johnson & Johnson buys medical device maker Laminar, cuts full-year earnings guidance
Johnson & Johnson JNJ said Thursday that its medical technology segment has acquired medical device maker Laminar Inc. in a…
Johnson & Johnson slips as Laminar acquisition prompts a profit outlook cut By Investing.com
Johnson & Johnson slips as Laminar acquisition prompts a profit outlook cut…
Johnson & Johnson, Ben Graham, And Defensive Stocks
…
[Latest] Global Organ Transplantation Market Size/Share Worth USD 21.5 Billion by 2032 at a 9.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…
Global Rotator Cuff Injury Treatment Market Size To Worth USD 1.66 Billion By 2032 | CAGR of 4.8%
The Rotator Cuff Injury Treatment Market was valued at USD 1.04 Billion in 2022 and the Global Rotator Cuff Injury…
Johnson & Johnson: Kursziel gesenkt
San Francisco (www.aktiencheck.de) - Rating-Update:
Larry Biegelsen, Analyst von Wells Fargo Advisors, bewertet die Aktie von Johnson & Johnson (J&J) (ISIN:…
Non-Oncology Biologics and Biosimilars Market is Booming and Expected to Grow at a CAGR of 21.8% to 2031
Companies covered in this report are AbbVie Inc., Sanofi, Amgen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La…
Global Cold Pain Therapy Market Size Worth USD 2.92 Billion by 2032 | CAGR of 5.2%
The Global Cold Pain Therapy Market Size was valued at USD 1.76 Billion in 2022 and the Worldwide Cold Pain…
Global Printing Ink Market Size Worth USD 35.93 Billion by 2032 | CAGR of 6.7%
The Global Cold Pain Therapy Market Size was valued at USD 1.76 Billion in 2022 and the Worldwide Cold Pain…
Johnson & Johnson and Intuitive Surgical Might Become Ozempics Next Victims. Are They Still Worth Buying?
With retailers worrying about Ozempics impact, healthcare stocks could be next.…
[Latest] Global Acne Treatment Market Size/Share Worth USD 18.77 Billion by 2032 at a 6.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…
Johnson Matthey Plc (JMPLF) Q2 2024 Earnings Call Transcript
…
Johnson Matthey Plc 2024 Q2 - Results - Earnings Call Presentation
…
Global Endoluminal Suturing Devices Market Size To Worth USD 285.58 Million By 2032 | CAGR of 11.6%
The Endoluminal suturing devices market was valued at USD 95.30 Million in 2022 and the Worldwide endoluminal suturing devices market…
Medical and Surgical Drainage System Market Exclusive Report with Detailed Analysis 2023-2031
Companies covered in this study are B. Braun SE, Becton, Dickinson and Company, Cardinal Health, Inc., Convatec Group Plc, Cook…
Dividend Roundup: General Mills, Nike, Johnson & Johnson, Marriott, and more
…
Johnson & Johnson, STERIS, and Prudential set for ex-dividend By Investing.com
Johnson & Johnson, STERIS, and Prudential set for ex-dividend…